BioXcel Corporation

BioXcel is a biopharmaceutical company pioneering the application of big data analytics and machine learning-based artificial intelligence integrated with drug development expertise, our R&D Engine, to advance the next wave of medicines and significantly improve the clinical and regulatory success of drug development. --------------------------- EvolverAI is designed to optimize therapeutic value of drugs, therapeutic modalities, disease biology and diseases. Our partners leverage EvolverAI to augment R&D decisions and increase probability of success (POS) by performing complex therapeutic area focused queries, with hundreds-to-thousands of proprietary therapeutic area specific probes designed by our drug discovery and translational experts. --------------------------- PharmGPS® Platform is a real-time, predictive, cognitive intelligence platform which provides actionable insights to help prioritize promising drugs. The platform is being used by industry leaders for designing, strategizing, developing and commercializing the next breakthrough treatments. PharmGPS® addresses all major therapeutic areas with a dedicated focus on immuno-oncology and orphan diseases. Visit www.bioxcel.com for more details. Connect with PharmGPS® on Twitter: @PharmGPS.